Sanne Duinkerken

Glycan-Modified Apoptotic Melanoma-Derived Extracellular Vesicles as Antigen Source for Anti-Tumor Vaccination

Sophie K. Horrevorts, Dorian A. Stolk, Rieneke van de Ven et al. · Cancers · 2019 · 95 citations · Full text

Medicine, Immunology, Oncology +17

Glyco-Dendrimers as Intradermal Anti-Tumor Vaccine Targeting Multiple Skin DC Subsets

Sanne Duinkerken, Sophie K. Horrevorts, Hakan Kalay et al. · Theranostics · 2019 · 67 citations · Full text

Medicine, Immunology, Oncology +17

Langerin-mediated internalization of a modified peptide routes antigens to early endosomes and enhances cross-presentation by human Langerhans cells

Cynthia M. Fehres, Sanne Duinkerken, Sven C. M. Bruijns et al. · Cellular and Molecular Immunology · 2015 · 45 citations · Full text

Life Sciences, Cell Biology, Immunology +17

Lipo-Based Vaccines as an Approach to Target Dendritic Cells for Induction of T- and iNKT Cell Responses

Dorian A. Stolk, Aram de Haas, Jana Vree et al. · Frontiers in Immunology · 2020 · 41 citations · Full text

Life Sciences, Immunology, Adaptive Immunity +16

Synergistic effects of dendritic cell targeting and laser-microporation on enhancing epicutaneous skin vaccination efficacy

Yoan Machado, Sanne Duinkerken, Veronika Hoepflinger et al. · Journal of Controlled Release · 2017 · 34 citations

Pharmacy, Dermatology, Immunology +16